Dibucaine

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Dibucaine
Generic name: DIBUCAINE 1%
Manufacturer: Geri-Care Pharmaceuticals, Corp
Product type: HUMAN OTC DRUG
SPL set ID: afe88610-5cac-960e-e053-2a95a90a7ba4
SPL ID: 29b472b9-6743-2403-e063-6294a90a22d0
Version: 4
Effective date: 2024-12-20
Source export date: 2026-10-30
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-30/0b630a6825fc0c8abba22d7c8fd4d069bde78bef928766047ddbb369119f337f/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run: 20261102T182004Z
Imported at: 2026-11-02 19:02:12

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M015	openfda.application_number
brand name		Dibucaine	openfda.brand_name
generic name		DIBUCAINE 1%	openfda.generic_name
manufacturer name		Geri-Care Pharmaceuticals, Corp	openfda.manufacturer_name
ndc	package	57896-131-01	openfda.package_ndc
ndc	product	57896-131	openfda.product_ndc
ndc11	package	57896013101	derived:openfda.package_ndc
rxcui		238784	openfda.rxcui
spl id		29b472b9-6743-2403-e063-6294a90a22d0	id
spl set id		afe88610-5cac-960e-e053-2a95a90a7ba4	set_id
unii		L6JW2TJG99	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For External use only Allergy alert Certain persons can develop allergic reactions to ingredients in this product. If the symptoms being treated do not subside or if redness, irritation, swelling, pain, or other symptoms develop or increase, discontinue use and ask a doctor.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.